NCT02989168View on ClinicalTrials.gov

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest

PHASE2TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

October 23, 2017

Study Completion Date

October 23, 2017

Conditions
Idiopathic Pulmonary FibrosisHypoxemia
Interventions
DRUG

GBT440

GBT440: Capsules which contain GBT440 drug substance in Swedish orange

Trial Locations (9)

19140

Philadelphia

35233

Birmingham

37232

Nashville

70122

New Orleans

80206

Denver

84108

Salt Lake City

SW3 6NP

London

M23 9QZ

Manchester

SO16 6YD

Southampton

Sponsors
All Listed Sponsors
lead

Global Blood Therapeutics

INDUSTRY